Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163958 | SCV000214556 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV003534435 | SCV000252928 | benign | Familial adenomatous polyposis 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000200153 | SCV000488420 | likely benign | Familial adenomatous polyposis 1 | 2016-03-23 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000163958 | SCV000681719 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-07 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000859105 | SCV001133346 | benign | not provided | 2019-01-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001174930 | SCV001338373 | likely benign | not specified | 2020-02-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000859105 | SCV001875418 | benign | not provided | 2015-05-12 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000163958 | SCV002535098 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-26 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV000200153 | SCV004017803 | benign | Familial adenomatous polyposis 1 | 2023-02-16 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV003954966 | SCV004782603 | likely benign | APC-related condition | 2023-02-16 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Department of Pathology and Laboratory Medicine, |
RCV000859105 | SCV001549884 | likely benign | not provided | no assertion criteria provided | clinical testing | The APC p.Val1750= variant was not identified in the literature nor was it identified in the following databases: MutDB, UMD-LSDB, Zhejiang Colon Cancer Database. The variant was identified in dbSNP (ID: rs2229997) as “With Likely benign allele”, ClinVar (as likely benign by Ambry Genetics, Invitae, Counsyl, and Color Genomics), Clinvitae (2x), Cosmic (in a tumour in the large intestine), and LOVD 3.0 (1x). The variant was identified in control databases in 13 of 245396 chromosomes at a frequency of 0.000053 (Genome Aggregation Database Feb 27, 2017). It was observed in the following populations: European (Non-Finnish) in 1 of 111010 chromosomes (freq: 0.000009), and Ashkenazi Jewish in 12 of 9812 chromosomes (freq: 0.001223); it was not observed in the African, Other, Latino, East Asian, European (Finnish), and South Asian populations. The p.Val1750= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |